SG11201704085QA - Heparan sulphates for use in repair and/or regeneration of skin - Google Patents

Heparan sulphates for use in repair and/or regeneration of skin

Info

Publication number
SG11201704085QA
SG11201704085QA SG11201704085QA SG11201704085QA SG11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA
Authority
SG
Singapore
Prior art keywords
regeneration
repair
skin
heparan sulphates
heparan
Prior art date
Application number
SG11201704085QA
Other languages
English (en)
Inventor
Simon Cool
Victor Nurcombe
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG11201704085QA publication Critical patent/SG11201704085QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
SG11201704085QA 2014-11-19 2015-11-19 Heparan sulphates for use in repair and/or regeneration of skin SG11201704085QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201408007P 2014-11-19
PCT/SG2015/050464 WO2016080916A1 (en) 2014-11-19 2015-11-19 Heparan sulphates for use in repair and/or regeneration of skin

Publications (1)

Publication Number Publication Date
SG11201704085QA true SG11201704085QA (en) 2017-06-29

Family

ID=56014304

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704085QA SG11201704085QA (en) 2014-11-19 2015-11-19 Heparan sulphates for use in repair and/or regeneration of skin

Country Status (6)

Country Link
US (1) US10471091B2 (ja)
EP (1) EP3220922B1 (ja)
JP (1) JP6709217B2 (ja)
CN (1) CN107249599A (ja)
SG (1) SG11201704085QA (ja)
WO (1) WO2016080916A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014185858A1 (en) 2013-05-16 2014-11-20 Agency For Science, Technology And Research Heparan sulphates
WO2016080915A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
AU2016323425B2 (en) 2015-09-15 2020-10-22 Savage Medical, Inc. Devices and methods for anchoring a sheath in a tissue cavity
WO2017126980A2 (en) 2016-01-18 2017-07-27 Fisher & Paykel Healthcare Limited Humidification of respiratory gases
JP6815782B2 (ja) * 2016-07-29 2021-01-20 小林製薬株式会社 α−ＳＭＡ産生抑制剤
CN106544318A (zh) * 2016-11-28 2017-03-29 广东万海细胞生物科技有限公司 促进脐带间充质干细胞定向分化为脂肪细胞的方法
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
WO2024080183A1 (ja) * 2022-10-14 2024-04-18 国立大学法人東海国立大学機構 糖鎖複合体、薬物担体、及びドラッグデリバリーシステム

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019087A (en) 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
JPH0240399A (ja) 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
GB9017008D0 (en) 1990-08-02 1990-09-19 Erba Carlo Spa Process for the enzymatic preparation of basic fibroblast growth factor
NO921495L (no) 1991-04-16 1992-10-19 Seikagaku Kogyo Co Ltd Oligosakkarid og fremgangsmaate for dets fremstilling
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
FR2812551B1 (fr) * 2000-08-07 2003-03-28 Virsol Forme pharmaceutique comprenant un materiau support a base de methylidene malonate et un facteur de regulation cellulaire
JP4768936B2 (ja) * 2000-08-07 2011-09-07 生化学工業株式会社 硫酸基を有するオリゴ糖
US20060183712A1 (en) 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
WO2010011185A1 (en) 2008-07-21 2010-01-28 Agency For Science, Technology And Research Stem cells obtained through in vitro culture with heparan sulfate
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
US9498494B2 (en) * 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
GB2463474B (en) 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
ES2650937T3 (es) 2008-11-20 2018-01-23 Laboratori Derivati Organici S.P.A. Composiciones dermatológicas que comprenden sulfato de heparano
FR2940610B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
US20130071443A1 (en) * 2011-09-16 2013-03-21 Agency For Science, Technology And Research Glycosaminoglycans
WO2014185858A1 (en) * 2013-05-16 2014-11-20 Agency For Science, Technology And Research Heparan sulphates
WO2016080915A1 (en) 2014-11-19 2016-05-26 Agency For Science, Technology And Research Cosmetic use of heparan sulphate

Also Published As

Publication number Publication date
JP2017536454A (ja) 2017-12-07
CN107249599A (zh) 2017-10-13
WO2016080916A1 (en) 2016-05-26
EP3220922A4 (en) 2018-07-11
US20170319615A1 (en) 2017-11-09
EP3220922B1 (en) 2020-10-14
EP3220922A1 (en) 2017-09-27
US10471091B2 (en) 2019-11-12
JP6709217B2 (ja) 2020-06-10

Similar Documents

Publication Publication Date Title
HK1251181A1 (zh) 組織修復和再生方法
IL258725A (en) Polypeptides with an extracellular cd80 site and their use in cancer therapy
RS59446B1 (sr) Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
SG11201704085QA (en) Heparan sulphates for use in repair and/or regeneration of skin
IL285104A (en) Device and method for tissue repair
ZA201704726B (en) Peptides and their use in the treatment of skin
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
HK1244012A1 (zh) 具有增强的抑制性質的抗trka抗體及其衍生物用於治療骨相關疼痛
IL248608A0 (en) Sulphites of hyperane
PL2910980T3 (pl) Sposób i układ do badania ciała ludzkiego z wykorzystaniem rozpraszania wstecznego
IL246855A0 (en) Materials for use in the treatment of retinitis
LT3373922T (lt) Kompozicijos ir būdai skirti naudoti homocistinurijos gydyme
PL3194968T3 (pl) Wykrywanie i traktowanie bydlęcego wirusa opryszczki
SG11201704086WA (en) Cosmetic use of heparan sulphate
GB201423270D0 (en) The combination for soothing and repair of the skin
IL255012A0 (en) Preparations and methods for treating skin conditions
GB201513964D0 (en) Improvements in or relating to emergency apparatus and/or methods
PL3262069T3 (pl) Zastosowanie przeciwciał i antagonistów skierowanych przeciwko LRG1 w leczeniu
SG11201701618SA (en) Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders
GB201508931D0 (en) Materials and methods for tissue regeneration
IL250244A0 (en) Prevention and treatment of inflammatory skin diseases
TH1601000569A (th) วิธีการสำหรับซ่อมแซมเส้นผมและผิวหนัง
ZA201408464B (en) Composition for the use in treatment of asthma
GB201411750D0 (en) Improvements in and relating to hinges